Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.

@article{Morice2007LongtermCO,
  title={Long-term clinical outcomes with sirolimus-eluting coronary stents: five-year results of the RAVEL trial.},
  author={Marie-claude Morice and Patrick Washington Serruys and Paul T Barragan and Christoph Bode and Gerrit-Anne van Es and H. J. Stoll and David B Snead and Laura Mauri and Donald E. Cutlip and Eduardo Sousa},
  journal={Journal of the American College of Cardiology},
  year={2007},
  volume={50 14},
  pages={1299-304}
}
OBJECTIVES This study examined the clinical outcomes at 5 years in RAVEL (A Randomized Comparison of a Sirolimus-Eluting Stent With a Standard Stent for Coronary Revascularization), the first controlled trial of drug-eluting stents. BACKGROUND The 6-month rate of angiographic coronary restenosis has been markedly lowered by sirolimus-eluting stents (SES). The long-term performance of drug-eluting stents, however, is under close scrutiny. METHODS The trial included 238 patients (mean age 60… CONTINUE READING